185 related articles for article (PubMed ID: 6331074)
1. Aging brain and dopamine receptors: abnormal regulation by CCK-8 of 3H-spiperone labeled dopamine receptors in striatal membranes.
Agnati LF; Fuxe K; Battistini N; Benfenati F
Acta Physiol Scand; 1984 Mar; 120(3):465-7. PubMed ID: 6331074
[No Abstract] [Full Text] [Related]
2. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
Clements-Jewery S; Robson PA
Neuropharmacology; 1981 Dec; 20(12B):1295-8. PubMed ID: 7322304
[No Abstract] [Full Text] [Related]
3. Selective modulation of 3H-spiperone labeled 5-HT receptors by subchronic treatment with the ganglioside GM1 in the rat.
Agnati LF; Benfenati F; Battistini N; Cavicchioli L; Fuxe K; Toffano G
Acta Physiol Scand; 1983 Feb; 117(2):311-4. PubMed ID: 6869038
[No Abstract] [Full Text] [Related]
4. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
Bennett JP; Wooten GF
Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
[TBL] [Abstract][Full Text] [Related]
5. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
Zahniser NR; Dubocovich ML
J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
[TBL] [Abstract][Full Text] [Related]
6. Interactions of a partial ergoline with dopamine receptors in vivo and in vitro.
Fuxe K; Goldstein M; Agnati LF; Köhler C; Lew JY; Okada K
Acta Physiol Scand; 1983 Feb; 117(2):303-5. PubMed ID: 6869037
[No Abstract] [Full Text] [Related]
7. Differential modulation by CCK-8 and CCK-4 of [3H]spiperone binding sites linked to dopamine and 5-hydroxytryptamine receptors in the brain of the rat.
Agnati LF; Fuxe K; Benfenati F; Celani MF; Battistini N; Mutt V; Cavicchioli L; Galli G; Hökfelt T
Neurosci Lett; 1983 Feb; 35(2):179-83. PubMed ID: 6304577
[No Abstract] [Full Text] [Related]
8. Striatal dopamine receptor function in morphine-tolerant dependent rats: influence of hypothalamic peptides.
Bhargava HN
NIDA Res Monogr; 1984 Mar; 49():320-6. PubMed ID: 6148693
[No Abstract] [Full Text] [Related]
9. Estimation of the apparent affinity of the striatal dopamine receptors for the radioligand[3H]spiperone [( 3H]spiroperidol).
Hruska RE
J Neurosci Res; 1984; 12(4):571-81. PubMed ID: 6512888
[TBL] [Abstract][Full Text] [Related]
10. Postsynaptic location of acrylamide-induced modulation of striatal 3H-spiroperidol binding.
Hong JS; Tilson HA; Agrawal AK; Karoum F; Bondy SC
Neurotoxicology; 1982 Jul; 3(1):108-12. PubMed ID: 6890181
[TBL] [Abstract][Full Text] [Related]
11. The effect of cholecystokinin octapeptide on rat striatal 3H spiperone binding.
O'Shaughnessy C; Poat JA; Turnbull MJ
Biochem Pharmacol; 1985 Aug; 34(15):2675-7. PubMed ID: 4015708
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D2 receptor dissociation constant for spiperone: identical values using 3H-labeled agonist or 3H-labeled antagonist.
Seeman P; Grigoriadis D
Biochem Pharmacol; 1985 Nov; 34(22):4065-6. PubMed ID: 4062976
[No Abstract] [Full Text] [Related]
13. Cataleptogenic doses of morphine suppress 3H-spiroperidol binding to striatal membranes.
Golembiowska-Nikitin K; Pilc A; Vetulani J
Naunyn Schmiedebergs Arch Pharmacol; 1982 May; 319(2):140-1. PubMed ID: 7202125
[TBL] [Abstract][Full Text] [Related]
14. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
Hancock AA; Marsh CL
Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
[TBL] [Abstract][Full Text] [Related]
15. Multiple daily amphetamine administration decreases both [3H]agonist and [3H]antagonist dopamine receptor binding.
Sibley DR; Weinberger S; Segal DS; Creese I
Experientia; 1982 Oct; 38(10):1224-5. PubMed ID: 6890464
[No Abstract] [Full Text] [Related]
16. [Relation between brain D2-dopamine receptors and 3H-spiperone binding sites of intact lymphocytes].
Noguchi-kuno SA; Nakata C; Nishitani H
Rinsho Shinkeigaku; 1983 Sep; 23(9):814-8. PubMed ID: 6232031
[No Abstract] [Full Text] [Related]
17. Analysis of dopamine interactions with [3H]-spiperone binding sites on rat corpus striatum membranes [proceedings].
Howlett DR; Nahorski SR
Br J Pharmacol; 1979 Jul; 66(3):468P-469P. PubMed ID: 526752
[No Abstract] [Full Text] [Related]
18. Cholecystokinin peptides in vitro modulate the characteristics of the striatal 3H-N-propylnorapomorphine sites.
Agnati LF; Celani MF; Fuxe K
Acta Physiol Scand; 1983 May; 118(1):79-81. PubMed ID: 6312748
[No Abstract] [Full Text] [Related]
19. Chronic proglumide increases [3H]spiperone binding in the rat brain.
Bean AJ; Baldy WJ; Martin GE
Eur J Pharmacol; 1985 Oct; 117(1):97-101. PubMed ID: 4085545
[TBL] [Abstract][Full Text] [Related]
20. Cation regulation differentiates specific binding of [3H]sulpiride and [3H]spiperone to rat striatal preparations.
Theodorou AE; Hall MD; Jenner P; Marsden CD
J Pharm Pharmacol; 1980 Jun; 32(6):441-4. PubMed ID: 6106685
[No Abstract] [Full Text] [Related]
[Next] [New Search]
